Published in Medicine and Law Weekly, January 14th, 2005
Both therapies are indicated to treat anemia by increasing hemoglobin levels and reducing the need for blood transfusions.
These interim results were from a randomized, open-label, multicenter study. The endpoints of this trial were hemoglobin response, transfusions, and safety in adult patients with chemotherapy-related anemia. Hemoglobin is the part of red blood cells that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly